Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors - 20/03/24
Doi : 10.1016/j.jaad.2023.11.037
Catherina X. Pan, MD a, b, Mofei Liu, MSPH c, Charles B. Lau, BA b, d, William C. Lau, BA b, e, Daniel Y. Kim, BS a, b, Shahin A. Saberi, BS a, b, Rachael Rowley, BS, MS b, Ruhi Kanwar, BS a, b, Anita Giobbie-Hurder, MS c, Nicole R. LeBoeuf, MD, MPH a, b, f, Vinod E. Nambudiri, MD, MBA, EdM a, b, f, ⁎ 
a Harvard Medical School, Boston, Massachusetts
b Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts
c Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts
d Boston University, Boston, Massachusetts
e Boston University School of Medicine, Boston, Massachusetts
f Dana-Farber Cancer Institute, Center for Cutaneous Oncology, Boston, Massachusetts
∗Correspondence to: Vinod E. Nambudiri, MD, MBA, EdM, Department of Dermatology, Brigham and Women's Hospital, 221 Longwood Ave, Boston, MA 02115Department of DermatologyBrigham and Women's Hospital221 Longwood AveBostonMA02115
Key words : BRAF, histopathology, immune checkpoint inhibitor, immune-related adverse events, immunotherapy, irAEs, lymphovascular invasion, melanoma, mitotic rate, NRAS, regression, toxicity, tumor infiltrating lymphocytes, tumor mutation
| Drs LeBoeuf and Nambudiri share senior authorship. |
|
| Funding sources: The article was supported in part by the Office of Scholarly Engagement, Harvard Medical School. |
|
| IRB approval status: Reviewed and exempted by institution, number 2021P003435. |
© 2023
American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 90 - N° 4
P. 826-829 - aprile 2024 Ritorno al numero
Articolo precedente
- Physician- and patient-reported dermatologic comorbidities of hypermobile Ehlers-Danlos syndrome
- Alan N. Snyder, Almeera Lateef, Nicholas Strat, Laura Andrews, Chelsea Shope, Cortney Gensemer, Bao Xin Liang, Taylor Petrucci, Mark Lavallee, Russel Norris, Dirk Elston
- Racial and ethnic differences in time to definitive surgery for melanoma: A retrospective study from the National Cancer Database
- Jennifer M. Fernandez, Tyler D. Evans, Makayla Schissel, Alfredo Siller, Erin X. Wei, Ashley Wysong
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?